MYBPC3 non-truncating variants in HCM cohorts


The table below lists the 272 rare (MAF<0.0001 in ExAC) non-truncating MYBPC3 variants identified in a cohort of 2912 HCM patients. When this rare variant frequency of 0.09341 is compared with a background population rate of 0.01884, there is a statistically significant case excess of 0.07457 (p<0.0001), which suggests that approximately 218 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (2912)LMM class ExAC frequency
1. c.3G>C p.Met1?missense 1Likely Pathogenic0.000000
2. c.103C>T p.R35Wmissense 1VUS0.000056
3. c.104G>A p.R35Qmissense 1VUS0.000079
4. c.223G>A p.D75Nmissense 1VUS favour pathogenic0.000091
5. c.290C>T p.A97Vmissense 1VUS favour pathogenic0.000000
6. c.326C>T p.A109Vmissense 1VUS0.000000
7. c.355G>A p.E119Kmissense 3VUS0.000000
8. c.373G>T p.A125Smissense 1VUS0.000000
9. c.436A>C p.T146Pmissense 1VUS0.000000
10. c.442G>A p.G148Rmissense 7VUS favour pathogenic0.000042
11. c.451G>A p.D151Nmissense 1VUS0.000041
12. c.481C>A p.P161Tmissense 1VUS favour pathogenic0.000041
13. c.518C>A p.T173Nmissense 1VUS0.000000
14. c.532G>A p.V178Mmissense 2VUS favour pathogenic0.000020
15. c.566T>A p.V189Dmissense 1VUS0.000000
16. c.636C>G p.S212Rmissense 2VUS favour pathogenic0.000000
17. c.655G>C p.V219Lmissense 8Likely Pathogenic0.000000
18. c.710A>C p.Y237Smissense 3Likely Pathogenic0.000000
19. c.713G>A p.R238Hmissense 1VUS0.000074
20. c.772G>A p.E258Kmissense 21Pathogenic0.000039
21. c.814C>T p.R272Cmissense 2VUS0.000083
22. c.844C>T p.R282Wmissense 1VUS favour pathogenic0.000000
23. c.853G>A p.D285Nmissense 1VUS0.000000
24. c.931T>A p.S311Tmissense 1VUS0.000000
25. c.932C>T p.S311Lmissense 1VUS0.000000
26. c.1021G>A p.G341Smissense 1VUS favour pathogenic0.000025
27. c.1037G>A p.R346Hmissense 2VUS0.000000
28. c.1188G>T p.W396Cmissense 1VUS0.000000
29. c.1213A>G p.M405Vmissense 1Pathogenic0.000000
30. c.1294G>A p.A432Tmissense 1VUS0.000037
31. c.1343T>C p.F448Smissense 1Likely Pathogenic0.000000
32. c.1358C>T p.P453Lmissense 1VUS0.000008
33. c.1397T>A p.M466Kmissense 1VUS0.000008
34. c.1418T>C p.F473Smissense 1VUS0.000000
35. c.1456T>G p.W486Gmissense 1Likely Pathogenic0.000000
36. c.1483C>T p.R495Wmissense 2VUS favour pathogenic0.000000
37. c.1483C>G p.R495Gmissense 4Likely Pathogenic0.000000
38. c.1484G>A p.R495Qmissense 10VUS favour pathogenic0.000008
39. c.1504C>T p.R502Wmissense 45Pathogenic0.000024
40. c.1505G>T p.R502Lmissense 1VUS favour pathogenic0.000000
41. c.1505G>A p.R502Qmissense 6Pathogenic0.000000
42. c.1513_1515delAAG inframe 2VUS favour pathogenic0.000000
43. c.1535T>A p.L512Qmissense 1VUS favour pathogenic0.000000
44. c.1540A>G p.I514Vmissense 1VUS0.000008
45. c.1586C>G p.T529Smissense 1VUS favour pathogenic0.000000
46. c.1591G>C p.G531Rmissense 1VUS favour pathogenic0.000017
47. c.1591G>A p.G531Rmissense 3VUS favour pathogenic0.000017
48. c.1624G>C p.E542Qmissense 17Likely Pathogenic0.000024
49. c.1672G>A p.A558Tmissense 1VUS0.000008
50. c.1766G>A p.R589Hmissense 2VUS0.000000
51. c.1778C>T p.S593Fmissense 1VUS favour pathogenic0.000034
52. c.1790G>A p.R597Qmissense 2VUS favour pathogenic0.000000
53. c.1828G>C p.D610Hmissense 2VUS favour benign0.000058
54. c.1828G>A p.D610Nmissense 3VUS0.000000
55. c.1841A>G p.Y614Cmissense 1VUS favour pathogenic0.000000
56. c.1934C>T p.P645Lmissense 2VUS0.000000
57. c.1950C>G p.D650Emissense 1VUS0.000000
58. c.1960C>T p.R654Cmissense 1VUS favour benign0.000008
59. c.2170C>T p.R724Wmissense 1VUS0.000019
60. c.2197C>T p.R733Cmissense 1VUS0.000085
61. c.2210C>T p.T737Mmissense 1VUS0.000050
62. c.2234A>G p.D745Gmissense 1VUS0.000000
63. c.2269G>A p.V757Mmissense 1VUS0.000066
64. c.2308G>A p.D770Nmissense 6Likely Pathogenic0.000008
65. c.2312T>C p.V771Amissense 1VUS0.000000
66. c.2320G>A p.A774Tmissense 2VUS0.000000
67. c.2374T>C p.W792Rmissense 5Likely Pathogenic0.000000
68. c.2429G>A p.R810Hmissense 8VUS favour pathogenic0.000033
69. c.2436G>T p.K812Nmissense 1VUS0.000000
70. c.2449C>T p.R817Wmissense 1VUS0.000000
71. c.2450G>A p.R817Qmissense 3VUS favour pathogenic0.000016
72. c.2459G>A p.R820Qmissense 1Likely Pathogenic0.000016
73. c.2518G>A p.V840Mmissense 1VUS0.000016
74. c.2525A>G p.Y842Cmissense 1VUS0.000000
75. c.2528_2536delAGATGCGCG p.Glu843_Arg845delinframe 1Pathogenic0.000000
76. c.2533C>T p.R845Cmissense 1VUS favour pathogenic0.000000
77. c.2557G>A p.G853Smissense 1VUS0.000008
78. c.2560A>G p.M854Vmissense 1VUS0.000000
79. c.2573G>A p.S858Nmissense 4VUS favour pathogenic0.000000
80. c.2641G>A p.V881Imissense 1VUS0.000018
81. c.2654C>T p.T885Mmissense 1VUS0.000022
82. c.2671C>T p.R891Wmissense 1Likely Pathogenic0.000031
83. c.2723A>G p.Y908Cmissense 1VUS0.000062
84. c.2828G>A p.R943Qmissense 1VUS0.000025
85. c.2873C>T p.T958Imissense 3VUS favour benign0.000065
86. c.2882C>T p.P961Lmissense 2VUS0.000048
87. c.2938C>T p.R980Cmissense 1VUS0.000062
88. c.2939G>A p.R980Hmissense 1VUS0.000000
89. c.2993A>G p.Q998Rmissense 1VUS favour pathogenic0.000000
90. c.3049G>A p.E1017Kmissense 1VUS favour benign0.000085
91. c.3064C>T p.R1022Cmissense 4VUS favour pathogenic0.000008
92. c.3065G>A p.R1022Hmissense 1VUS favour pathogenic0.000000
93. c.3065G>C p.R1022Pmissense 1VUS favour pathogenic0.000025
94. c.3083C>G p.T1028Smissense 1VUS0.000000
95. c.3098G>A p.R1033Qmissense 1VUS0.000000
96. c.3277G>T p.G1093Cmissense 1VUS0.000020
97. c.3281A>T p.N1094Imissense 1VUS0.000000
98. c.3373G>A p.V1125Mmissense 1VUS favour pathogenic0.000022
99. c.3413G>C p.R1138Pmissense 1VUS0.000000
100. c.3415G>A p.V1139Imissense 1VUS0.000087
101. c.3548T>G p.F1183Cmissense 1Likely Pathogenic0.000000
102. c.3580G>A p.A1194Tmissense 1VUS0.000008
103. c.3605G>A p.C1202Ymissense 1Likely Pathogenic0.000000
104. c.3676C>T p.R1226Cmissense 1VUS0.000058
105. c.3742G>A p.G1248Rmissense 1VUS0.000033
106. c.3742_3759dup p.Gly1248_Cys1253dupinframe 4Likely Pathogenic0.000000
107. c.3746G>T p.G1249Vmissense 1VUS0.000000
108. c.3763G>A p.A1255Tmissense 1VUS favour pathogenic0.000075
109. c.3767_3769delCCA p.Thr1256delinframe 3Likely Pathogenic0.000000
110. c.3791G>A p.C1264Ymissense 1VUS0.000008
111. c.3797G>A p.C1266Ymissense 1Likely Pathogenic0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015 Nov;17(11):880-8.